Centessa Pharmaceuticals is Drug Discovery in United Kingdom that focus on Centessa Pharmaceuticals PLC business. Founded in 2020. They cover business area such as Centessa Pharmaceuticals PLC, its portfolio, disease, high unmet, oncology, hematology, immunology, inflammation, neuroscience, its product, Lixivaptan, (Oral.
2020
( 4 years old in 2024 )
Centessa Pharmaceuticals PLC
-
The Dorothy Hodgkin Building Babraham
Research Campus, Babraham
Cambridge CB22 3FH
England, United Kingdom
Private
Centessa Pharmaceuticals PLCits portfoliodiseasehigh unmetoncologyhematologyimmunologyinflammationneuroscienceits productLixivaptan(Oral
* We use standard office opening hours in near Centessa Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Centessa Pharmaceuticals is Drug Discovery business from United Kingdom that founded in 2020 (4 years old in 2024), Centessa Pharmaceuticals business is focusing on Centessa Pharmaceuticals PLC.
Centessa Pharmaceuticals headquarter office and corporate office address is located in The Dorothy Hodgkin Building Babraham Research Campus, Babraham Cambridge CB22 3FH England, United Kingdom.
Centessa Pharmaceuticals was founded in United Kingdom.
In 2024, Centessa Pharmaceuticals is currently focus on Centessa Pharmaceuticals PLC sector.
Above is snippet of Google Trends for "Centessa Pharmaceuticals PLC" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Centessa Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
